Tested Applications
| Positive FC detected in | human bone marrow mesenchymal stromal cells, human blood cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Flow Cytometry (FC) | FC : 0.25 ug per 10^6 cells in a 100 µl suspension |
| This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
65585-1-MR targets STRO-1 in FC applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Host / Isotype | Mouse / IgG2a |
| Class | Recombinant |
| Type | Antibody |
| Immunogen |
Human CD34 positive bone marrow cells Predict reactive species |
| Full Name | STRO-1 |
| Gene Symbol | |
| Gene ID (NCBI) | |
| RRID | AB_3670335 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Protein A purification |
| Storage Buffer | PBS with 0.09% sodium azide, pH 7.3. |
| Storage Conditions | Store at 2-8°C. Stable for one year after shipment. |
Protocols
| Product Specific Protocols | |
|---|---|
| FC protocol for STRO-1 antibody 65585-1-MR | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The Anti-Human STRO-1 (STRO-1) Mouse IgG2a Recombinant Antibody (Cat# 65585-1-MR) has 1 total citation. It appears in EBioMedicine (IF 11.2), published in 2026, in a study investigating how Parvimonas micra exacerbates periodontitis by infiltrating host cells through TmpC and circumventing lysosomal elimination via AppA. The associated research field is infectious disease and periodontal biology.
| Species | Application | Title |
|---|---|---|
EBioMedicine Parvimonas micra exacerbates periodontitis by infiltrating host cells through TmpC and circumventing lysosomal elimination via AppA. |





